INDIGO Biosciences Welcomes New Member to Board of Directors
August 13, 2019
Mark McLoughlin Brings Four Decades of Healthcare Industry Experience to the Company’s Board State College, PA – INDIGO Biosciences, Inc. (INDIGO), the recognized industry leader in nuclear receptor and in vitro toxicology testing solutions, announced the appointment of Mark McLoughlin to the Company’s Board of Directors. Mark brings four decades of healthcare industry experience to the Board. Mark McLoughlin [...]
Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic
August 13, 2019
Extended collaboration leveraging Schrödinger’s computational platform includes new terms with increased and additional milestone payments to Schrödinger NEW YORK – Schrödinger today announced an expansion of its computational design collaboration with Morphic Therapeutic (“Morphic”), a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics that Schrödinger co-founded with Harvard Professor Timothy Springer, [...]
Dovetail Genomics® Launches Omni-C™ Technology
August 13, 2019
New Hi-C Kit Offers a Powerful New Tool to Help Researchers Expand Their Understanding of Genome Structure, Generate High Quality Genome Assemblies and Detect Genetic Variants SCOTTS VALLEY, Calif. -- Dovetail Genomics, the industry leader in advanced genomic solutions for proximity ligation, today announced the global availability of its latest Hi-C offering, Omni-C. The new kit offers [...]
August 12, 2019
The alliance will leverage Mission Bio’s Tapestri Platform to investigate Onconova’s novel cancer therapy rigosertib, through clinical trials NEWTOWN, Pa. and SOUTH SAN FRANCISCO, Calif., August 12, 2019 -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company discovering and developing novel products to treat cancer, with a focus on Myelodysplastic Syndromes (MDS), [...]
Thorlabs Adds to its Raman Spectroscopy Capabilities via Acquisition of Coda Devices
August 12, 2019
Newton, NJ and Menlo Park, CA – Thorlabs announced today that effective as of August 1, 2019 it completed the acquisition of Coda Devices, a manufacturer of Raman-based solutions for analyzing the chemical composition of substances within a laboratory environment or out in the field. Based out of Menlo Park, California with an R&D center [...]
August 12, 2019
The workstations are ideal for spectroscopy experiments in the vacuum ultraviolet regime, potentially advancing quantum information science and engineering. Spectroscopy was central to the development of quantum mechanics, including blackbody radiation and Einstein’s photoelectric effect. There are two experimental kits available, diagnostic and analytical. The diagnostic system equips the spectrometer with a sensitive CCD detector. Use it to measure spectral [...]
ForteBio introduces high precision Octet system biosensor for process development rigor
August 12, 2019
ForteBio, the Biologics Business Unit of Molecular Devices, announced today at Bioprocessing Summit in Boston, the release of the new High Precision Streptavidin 2.0 (SAX2) biosensor for the Octet® platform. Focused on meeting customers’ needs to minimize variability from consumables, the SAX2 biosensors are controlled to meet the most stringent of assay precision requirements with [...]
August 12, 2019
Find out how Adam Equipment’s TBB mechanical triple beam balance helped approximately 4,000 year 5 and 6 pupils across Cambridgeshire compete in The Energy Challenge, an AstraZeneca STEM competition for schools. Adam Equipment is committed to inspiring young people’s experience in the classroom through the use of visual and interactive learning methods. We are proud [...]
ABB names Björn Rosengren as CEO
August 11, 2019
Zurich, Switzerland | The Board of ABB has unanimously appointed Björn Rosengren, as Chief Executive Officer. He will join ABB on February 1, 2020 and succeed CEO, Peter Voser, in this role on March 1, 2020. At that time Peter Voser will revert to his position at ABB solely as Chairman of the Board. Björn Rosengren [...]
908 Devices launches the Rebel, the first at-line spent cell media analyzer for bioprocess labs
August 10, 2019
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the launch of their new bioprocess analyzer, the Rebel™. This first-of-its-kind, miniature CE-MS-based analyzer lets biopharma researchers accelerate process development cycles and maximize their bioreactor utilization by running media analysis at-line, anytime. The company is presenting the Rebel for the first [...]

